navbar brand navbar brand
  • Course Catalog
  • Event Calendar
  • Contact Us

You are being redirected to another site.


Back to Post List
New Post
Title(*)
Description
  • Introduction
Click on the on the top progress bar to review the step.
MDS Parkinson's Disease Educational Course for Industry Professionals
Course Format
In-Person
Start Date
Sat, May 23, 2026
End Date
Sat, May 23, 2026
Course Location
Phoenix, Arizona
...
Program Description

As the premier medical society in the world that focuses on movement disorders, MDS is uniquely positioned to provide a program that will help industry professionals better understand Parkinson’s disease and give them the ability to work in a more informed manner. The primary purpose of this program is to provide industry professionals with a basic knowledge of Parkinson's disease from a diagnostic and therapeutic perspective, empowering them to better understand the challenges of this disorder and its treatment.

 

This program will take place on May 23, 2026 in Phoenix, AZ, USA ahead of the World Parkinson’s Congress.

Registration Type Member Fee Non-Member Fee
Course Registration $800.00 $800.00
You cannot participate in this course
Course Location

Phoenix, Arizona USA
Click here to view location map

Contact Us
MDS Development
development@movementdisorders.org
Course Overview (Fees, Schedule, & Course Details)

Course Schedule  Course Faculty


REGISTRATION FEES
Members: $800 USD
Non-Members: $800 USD

*Companies sending three or more participants and served as sponsors of the 2025 International Congress of Parkinson’s Disease and Movement Disorders in Honolulu, HI are eligible for a 15% discount on registration fees.


COURSE VENUE

Phoenix, AZ, United States


LEARNING OBJECTIVES

Upon completion of this activity, learners will be able to:

1. Recognize the differential diagnosis of Parkinson’s disease

2. Discuss the clinical features of Parkinson’s disease from early to advanced stages

3. Identify the benefits, limitations and complications of currently available treatments for PD including pharmacotherapy and surgery

4. Discuss non-motor features of Parkinson’s disease

5. Identify outcome measures, unmet needs, emerging therapies, and biomarkers for Parkinson’s disease


INTENDED AUDIENCE

This activity is intended for industry professionals who work for pharmaceutical and medical device companies.

Copyright © 1998-2026 International Parkinson and Movement Disorder Society (MDS). All Rights Reserved.

Processing...
×